Veritas’ Gives Update for 2018 and Revenue Plan for 2019

Revenue Outlook
Human Trials of CTL-X in Puerto Rico
Cancer project downgraded
Cannevert’s dealer license amendment
Revenue Outlook
Human Trials of CTL-X in Puerto Rico
Cancer project downgraded
Cannevert’s dealer license amendment